Maureen Pickarski

3.1k total citations · 1 hit paper
21 papers, 1.8k citations indexed

About

Maureen Pickarski is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Maureen Pickarski has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Orthopedics and Sports Medicine. Recurrent topics in Maureen Pickarski's work include Bone health and treatments (15 papers), Bone Metabolism and Diseases (14 papers) and Bone health and osteoporosis research (6 papers). Maureen Pickarski is often cited by papers focused on Bone health and treatments (15 papers), Bone Metabolism and Diseases (14 papers) and Bone health and osteoporosis research (6 papers). Maureen Pickarski collaborates with scholars based in United States, Austria and Sweden. Maureen Pickarski's co-authors include Le T. Duong, Gregg Wesolowski, Tadashi Hayami, Ya Zhuo, Gideon A. Rodan, Ashleigh Bone, P. Masarachia, Brenda L Pennypacker, Boyd B. Scott and Donald B. Kimmel and has published in prestigious journals such as Journal of Bone and Mineral Research, Molecular Pharmacology and Bone.

In The Last Decade

Maureen Pickarski

21 papers receiving 1.8k citations

Hit Papers

Characterization of articular cartilage and subchondral b... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers

Maureen Pickarski
Simon Blake United States
Maureen Pickarski
Citations per year, relative to Maureen Pickarski Maureen Pickarski (= 1×) peers Simon Blake

Countries citing papers authored by Maureen Pickarski

Since Specialization
Citations

This map shows the geographic impact of Maureen Pickarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Pickarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Pickarski more than expected).

Fields of papers citing papers by Maureen Pickarski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Pickarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Pickarski. The network helps show where Maureen Pickarski may publish in the future.

Co-authorship network of co-authors of Maureen Pickarski

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Pickarski. A scholar is included among the top collaborators of Maureen Pickarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Pickarski. Maureen Pickarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duong, Le T., Maureen Pickarski, Hilde Giezek, et al.. (2022). Effects of odanacatib on bone-turnover markers in osteoporotic postmenopausal women: a post hoc analysis of the LOFT study. Osteoporosis International. 33(10). 2165–2175. 2 indexed citations
2.
Misof, Barbara M., Paul Roschger, Charles Chen, et al.. (2016). Effects of odanacatib on bone matrix mineralization in rhesus monkeys are similar to those of alendronate. Bone Reports. 5. 62–69. 3 indexed citations
3.
Duong, Le T., Maureen Pickarski, Ya Zhuo, et al.. (2016). Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys. Bone. 88. 113–124. 15 indexed citations
4.
Pickarski, Maureen, et al.. (2015). Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis. Oncology Reports. 33(6). 2737–2745. 40 indexed citations
5.
Muise, Eric S., Alexei A. Podtelezhnikov, Maureen Pickarski, et al.. (2015). Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate. Journal of Bone and Mineral Research. 31(4). 839–851. 12 indexed citations
6.
Wesolowski, Gregg, et al.. (2014). Comparing the disease modifying effects of alendronate to risedronate in the rat anterior cruciate ligament transection model of osteoarthritis. Osteoarthritis and Cartilage. 22. S463–S463. 1 indexed citations
7.
Jacome-Galarza, Christian E., Do Y. Soung, Naga Suresh Adapala, et al.. (2014). Altered Hematopoietic Stem Cell and Osteoclast Precursor Frequency in Cathepsin K Null Mice. Journal of Cellular Biochemistry. 115(8). 1449–1457. 17 indexed citations
8.
Duong, Le T., Gregg Wesolowski, Patrick P.S. Leung, Renata M. Oballa, & Maureen Pickarski. (2014). Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis. Molecular Cancer Therapeutics. 13(12). 2898–2909. 68 indexed citations
10.
Hayami, Tadashi, Ya Zhuo, Gregg Wesolowski, Maureen Pickarski, & Le T. Duong. (2012). Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone. 50(6). 1250–1259. 110 indexed citations
11.
Pickarski, Maureen, Tadashi Hayami, Ya Zhuo, & Le T. Duong. (2011). Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. BMC Musculoskeletal Disorders. 12(1). 197–197. 73 indexed citations
13.
Pickarski, Maureen, et al.. (2011). The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone. 49(4). 623–635. 90 indexed citations
14.
Masarachia, P., Brenda L Pennypacker, Maureen Pickarski, et al.. (2011). Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys. Journal of Bone and Mineral Research. 27(3). 509–523. 95 indexed citations
15.
Kossodo, Sylvie, Maureen Pickarski, Shu-An Lin, et al.. (2009). Dual In Vivo Quantification of Integrin-targeted and Protease-activated Agents in Cancer Using Fluorescence Molecular Tomography (FMT). Molecular Imaging and Biology. 12(5). 488–499. 70 indexed citations
16.
Leung, Patrick P.S., Maureen Pickarski, Gregg Wesolowski, & Le T. Duong. (2008). P6. Anti-resorptive and potential anti-invasion effects of a cathepsin K inhibitor in the treatment of breast cancer-induced bone metastasis. Cancer Treatment Reviews. 34. 14–14. 1 indexed citations
17.
Desmarais, Sylvie, W. Cameron Black, Renata M. Oballa, et al.. (2007). Effect of Cathepsin K Inhibitor Basicity on in Vivo Off-Target Activities. Molecular Pharmacology. 73(1). 147–156. 61 indexed citations
18.
Watters, James, Chun Cheng, Maureen Pickarski, et al.. (2007). Inverse relationship between matrix remodeling and lipid metabolism during osteoarthritis progression in the STR/ORT mouse. Arthritis & Rheumatism. 56(9). 2999–3009. 30 indexed citations
19.
Hayami, Tadashi, Maureen Pickarski, Ya Zhuo, et al.. (2005). Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone. 38(2). 234–243. 535 indexed citations breakdown →
20.
Hayami, Tadashi, Maureen Pickarski, Gregg Wesolowski, et al.. (2004). The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis & Rheumatism. 50(4). 1193–1206. 464 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026